Evaluating the effect of mobile applications “My A:Care” and “Smart Coach” on adherence to lipid-lowering treatment in patients with dyslipidemia: a prospective, randomized, open-label clinical study
BackgroundDyslipidemia, a key modifiable risk factor for cardiovascular diseases, is managed using lipid-lowering therapies. Medication adherence for dyslipidemia treatment is poor across the globe, impacting treatment effectiveness. This highlights the need for scalable strategies, such as mobile a...
Saved in:
| Main Authors: | Chatlert Pongchaiyakul, Stefan Driessen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Digital Health |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fdgth.2025.1502990/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The silent epidemic of non-adherence – insights from the 2024 a:care congress
by: Sheri D. Pruitt, et al.
Published: (2025-05-01) -
Despite the pandemic: upward trajectories of medication adherence and persistence in patients with dyslipidemia
by: Jieun Jang, et al.
Published: (2024-12-01) -
Prevalence of Dyslipidemia, Drug Therapy Problems, and Medication Adherence in Type 2 Diabetes Mellitus Patients in North Central Nigeria
by: F.O. Aliyu, et al.
Published: (2024-06-01) -
Adherence to antihypertensive medications and its determinants among adult hypertensive patients
by: Sindu Punna, et al.
Published: (2022-10-01) -
Factors related to adherence to treatment for systemic hypertension
by: Silvana Maria Coelho Leite Fava, et al.
Published: (2014-06-01)